CuraTeQ Biologics receives positive opinion for biosimilar Dyrupeg from EMA
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
Subscribe To Our Newsletter & Stay Updated